Equius Partners’s Amgen AMGN Stock Holding History

Equius Partners’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$207K	Buy	+787	New	+$211K	0.06%	23

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Equius Partners's AMGN Position: Q4 2022 in Review

Equius Partners opened a new position in Amgen (AMGN) in Q4 2022: 787 shares worth $207K. The stake represents 0.06% of the portfolio and ranks #23 among its holdings.

2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

Equius Partners held 787 shares of Amgen worth $207K as of Q4 2022.
Amgen was a new Equius Partners position in Q4 2022.
Amgen made up 0.06% of Equius Partners's portfolio in Q4 2022, its #23 holding.
2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Equius Partners's 13F filing for Q4 2022, filed 27 Jan 2023.